The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Clinical Trial Simulation: A Review
Abstract
Modeling and simulation in general, and specifically clinical trial simulation (CTS), have been recognized by the (larger) pharmaceutical companies and regulatory authorities as being pivotal to improving the efficiency of the drug development process. This includes the use of CTS to learn about drug effectiveness and safety and to optimize trial designs at the various stages of development. By reviewing papers published during the period January 2000-January 2010, this paper discusses recent developments with respect to methodology, applications, and lessons learned in the use of CTS in the development and clinical use of specific drugs. It is expected that future CTS experiments will be aided by the hybridization of optimal design methods with computationally intensive stochastic simulations. This will take advantage of optimizing the experimental design and leave the task of evaluating the probable real-world performance of a limited number of candidate trial designs and analysis procedures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Learning versus confirming in clinical drug development*
Sheiner, L. B. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90160-0 · Cited by 633
Nestorov, I., Graham, G., Duffull, S., Aarons, L., Fuseau, E., & Coates, P. (2001) · Pharmaceutical Research · doi:10.1023/a:1010943430471 · Cited by 41
Cited by
Computational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
Workgroup, E. M., Marshall, S., Burghaus, R., Cosson, V, Cheung, S., Chenel, M., DellaPasqua, O., Frey, N., Hamrén, B., Harnisch, L., et al. (2016) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12049 · Cited by 373
“As highlighted by Holford et al.101 in their review, assumption-making is an inherent feature of CTS, it is, therefore, important that they are adequately described in the simulation and prediction plan.”
BackgroundPharmacokinetic-Pharmacodynamic Modeling of Antibacterial Drugs
Nielsen, E. I., & Friberg, L. E. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005769 · Cited by 332
Machine Learning in Pharmacometrics: Opportunities and Challenges
McComb, M., Bies, R., & Ramanathan, M. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14801 · Cited by 128
“141,142 Allen et al. 143 described a method to generate virtual patients that simulates a biologically plausible range of output from a desired model followed by the use of a modified sum-of-squared errors cost function that compares the simulated values to real-world data to obtain a new virtual…”
MethodA tutorial on RxODE: simulating differential equation pharmacometric models in R
Wang, W., Hallow, K., & James, D. (2016) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12052 · Cited by 107
A practical guide for the generation of model-based virtual clinical trials
Craig, M., Gevertz, J. L., Kareva, I., & Wilkie, K. P. (2023) · Frontiers in Systems Biology · doi:10.3389/fsysb.2023.1174647 · Cited by 52
Bueters, T., Ploeger, B. A., & Visser, S. A. G. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.05.001 · Cited by 43
Self-citationGenerating Digital Twins with Multiple Sclerosis Using Probabilistic Neural Networks
Walsh, J. R., Smith, A. M., Pouliot, Y., Li-Bland, D., Loukianov, A., Fisher, C. K., & for the Multiple Sclerosis Outcome Assessments Consortium (2020) · doi:10.1101/2020.02.04.934679 · Cited by 40
Alternative strategies in cardiac preclinical research and new clinical trial formats
Kreutzer, F. P., Meinecke, A., Schmidt, K., Fiedler, J., & Thum, T. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvab075 · Cited by 36
The use of real-world data in drug repurposing
Park, K. (2021) · Translational and Clinical Pharmacology · doi:10.12793/tcp.2021.29.e18 · Cited by 22
“Traditionally, clinical trial simulation (CTS) uses virtual populations to test various trial designs before conducting the actual clinical trial [30].”
BackgroundJanssen, J. M., Zwaan, C. M., Schellens, J. H. M., Beijnen, J. H., & Huitema, A. D. R. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.07.050 · Cited by 6
Metadata
- Authors
- Holford, N., Ma, S. C., & Ploeger, B. A.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2010-07-07
- Volume
- 88
- Issue
- 2
- Pages
- 166-182
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W1971463294
- Cited by
- 191
- References
- 2
- FWCI
- 14.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.